| General details |
| Tax Identification Number (N.I.F): A-96184882 |
| Company name: Laboratorio Reig Jofre SA |
| Abbreviated name: Reig Jofre |
| Sector: Pharma |
| Legal Entity Identifier (LEI): 9598003MRMJHA81QJF20 |
| Share capital |
| Number of shares: 79,635,945 |
| Par value: 0.50 euros/share |
| Ordinary stock: 39,817,972,50 Euros |
| Number of attributed voting rights: 79,635,945 |
| Number of shares required for each voting right: 1 |
| Stock market trading |
| Share identification number (ISIN): ES0165359029 |
| Incorporation to the interconnected trading system: 29/11/2002 |
| Markets: Barcelona, Bilbao, Madrid and Valencia |
| Trading ticker: RJF/AC |
| Trading type: Equities only |
| 62.7% – Reig Jofre Investments SL |
| 10.1% – Kaizaharra Corp |
| 6.1% – Onchena, SL |
| 3.0% – Quaero Capital |
| 17.4% – Free float |
| 0.7% – Treasury Stock |
On September 22, 2015 the cancellation and consolidation of shares (reverse split) approved by the Ordinary and Extraordinary General Shareholders’ Meeting of Laboratorio Reig Jofre SA of June 11, 2015 was formalized with an exchange ratio of 20 existing shares for every new share.
Summary of the reverse split:.
Before the reverse split
Shares composing the share capital: 1,264,284,408
Par value: 0.10 euros/share
ISIN number: ES0165359011
After the reverse split
Shares composing the share capital: 63,214,220
Par value: 2.00 euros/share
ISIN number: ES0165359029
On June 30, 2022, the company owned 728,579 own shares, representing 0.94% of the share capital.
Reig Jofre currently holds no shareholding in any listed company.